[Federal Register: August 16, 2005 (Volume 70, Number 157)]
[Notices]
[Page 48134-48135]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16au05-74]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement DP05-130]
Epidemiologic Study of Inflammatory Bowel Disease; Notice of
Intent To Fund Single Eligibility Award
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
intent to fund fiscal year (FY) 2005 funds for a cooperative agreement
program to expand on preliminary findings of Inflammatory Bowel Disease
(IBD) in the United States and enhance our understanding of the
demographic and clinical characteristics of IBD, variations in clinical
practice, and the impact of the disease. This announcement will build
on a previous epidemiologic study of the disease and be used to target
interventions for groups at high risk for IBD and inform best clinical
practices.
The Catalog of Federal Domestic Assistance number for this program
is 93.945.
B. Eligible Applicant
Assistance will be provided only to the Crohn's and Colitis
Foundation of America.
The Crohn's and Colitis Foundation of America is the only
institution eligible to submit an application in response to this RFA.
The CCFA was referenced by the House and Senate in their Labor/Health
and Human Services/Education (L/HHS/Ed) Committee Reports. The House
language states: ``For the past five years, the Committee has
encouraged CDC to work in partnership with the IBD community to
establish a national IBD epidemiology program to further our
understanding of these diseases. The Committee understands that the
Crohn's and Colitis Foundation of America has provided financial
support through the CDC Foundation to initiate this important program.
Now that the project is established, the Committee encourages CDC to
contribute to the project in order to expand the work in FY2005.'' The
Senate language states: ``An epidemiological study of IBD is needed to
gain a better understanding of the prevalence of IBD in the United
States and the demographic characteristics of the IBD patient
population. Over the last 3 years, the Crohn's and Colitis Foundation
of America has provided the CDC with $750,000 to initiate the
epidemiological study. Now that the project has been established
through an investment by the patient community, the Committee has
provided $800,000 to continue this study.'' The Conference Committee
recommended a total of $750,000.
The CCFA is a not-for-profit 501 (c)(03) organization, founded in
1967 ``to cure and prevent Crohn's disease and ulcerative colitis
through research, and to improve the quality of life of children and
adults affected by these digestive disease through education and
support''. Since 1967, CCFA has established itself as the leading
agency in the country on IBD research. It has led the efforts in
identifying the research needs and developing successful strategies to
meet those needs. CCFA has a national scientific advisory committee
comprised of nationally renowned physicians and scientists in the field
of inflammatory bowel disease. This advisory committee is the only one
of its kind in the country dedicated solely to identifying and
supporting emerging areas of research that could lead to the
understanding of the causes and disease course of IBD. Through this
scientific advisory committee and other partnerships, CCFA has
developed several major initiatives to advance IBD research.
For the past three years, the CCFA scientific advisory committee
has worked with the CDC to establish the informational infrastructure
needed to conduct IBD research. They have built a validated disease
algorithm for identifying patients with IBD and estimating the
prevalence of the disease. Only CCFA has access to these algorithms and
the informational infrastructure. CCFA will use the algorithms and
infrastructure created, to further describe the prevalence and
incidence of IBD and the impact of various clinical practices on
outcomes.
The mission of CCFA, the organization's extensive network of
resources, and the existing collaborative efforts with the CDC make it
highly probable that CCFA will successfully achieve the activities
identified in Section 1 of this RFA. CCFA is the only not-for-profit
national IBD organization that promotes and provides funding for much
needed IBD research. This characteristic of CCFA is unmatched by any
other public or private IBD specific organization currently conducting
similar activities in the United States.
The CCFA has partnered with the CDC in the establishment and
initiation of this study; therefore, it is the only eligible
organization to collaborate in the completion of this study.
C. Funding
Approximately $700,000 is available in FY 2005 to fund this award.
It is
[[Page 48135]]
expected that the award will begin on or before August 31, 2005, and
will be made for a 12-month budget period within a project period of up
to five years. Funding estimates may change.
D. Where To Obtain Additional Information
For general comments or questions about this announcement, contact:
Technical Information Management, CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA 30341-4146, telephone: 770-488-2700.
For technical questions about this program, contact: Brenda Colley
Gilbert, Project Officer, 4770 Buford Highway N.E., Mailstop K-92,
Atlanta, GA 30341, telephone: 770-488-8390, e-mail:
BColleyGilbert@cdc.gov.
Dated: August 10, 2005.
Alan A. Kotch,
Deputy Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-16172 Filed 8-15-05; 8:45 am]
BILLING CODE 4163-18-P